Drug recall · April 24, 2019
Remifentanil HCl active pharmaceutical ingredient recall
Why: Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass container, Rx ONLY, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742.
- Lots / codes
Lot #: B1319-170101
- Quantity
- 416.95 g glass container
- Company
- Johnson Matthey Inc., West Deptford, NJ
- Distribution
- Product was distributed to one manufacturer in Morgantown, WV who may have manufactured the product into finished product and further distribute to the retail level Nationwide in the USA.
- Initiated
- April 2, 2019 · Voluntary: Firm initiated
- Classified
- April 30, 2019
- Reported
- April 24, 2019
- Ended
- January 10, 2020
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Remifentanil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.